In this article, we discuss the 15 stocks that could mint millionaires in 2026.
For more than a century, investing in the stock market in the United States has represented one of the most accessible paths to generating substantial wealth for the amateur investor, with a long and storied history that shows disciplined, long-term equity investing can turn ordinary savers into millionaires. Some important contributing factors to this are time, compound returns, diversification, and staying invested through market turbulence. A recent finance commentary by Fisher Investments, published by news agency Reuters, stressed the importance of compound returns for investors, arguing that how long a person invests matters more than the time at which the stock was bought.
Equity also remains a major driver of household wealth. In the US, for instance, Reuters reports that $5.51 trillion of the $7.09 trillion increase in net household wealth in the second quarter of 2025 stemmed from rising equity prices. This underscores how, for many investors, the stock market is the principal vehicle for wealth accumulation. Indeed, the affluent tend to have a higher equity allocation, which magnifies their upside over multi-decade investing horizons. The shift in investor flows hints at where opportunities may lie. According to Reuters, investors have pulled $152 billion from US growth funds in the first nine months of 2025, even as the S&P 500 hit record highs, signaling rotation toward undervalued sectors and small caps.
Our Methodology
For this article, we used stock screeners to identify stocks with more than $2 billion in market capitalization that have a revenue growth and EPS growth rate of above 15%, as well as analysts’ upside potential of over 50% as of December 18. The top fifteen companies were selected and ranked in ascending order of their upside potential. These stocks are also popular among hedge funds, according to Insider Monkey’s database of Q3 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
Stocks That Could Mint Millionaires in 2026
15. Dutch Bros Inc. (NYSE:BROS)
Number of Hedge Fund Holders: 46
Next Year Revenue Growth: 25%
Next Year EPS Growth: 32%
Analyst Upside: 51%
Dutch Bros Inc. (NYSE:BROS) is one of the stocks that could mint millionaires in 2026.
On December 17, KeyBanc analyst Christopher Carril initiated coverage of Dutch Bros Inc. (NYSE:BROS) stock with an Overweight rating and $77 price target. In an investor note, the analyst noted that the company represented one of the most compelling growth stories, driven by mid-teens unit growth, and while shares had outperformed peers in 2025, the performance had not fully reflected strong fundamentals, as sentiment around the fast casual segment remained largely negative. The company’s sales drivers in 2026 were highly visible, including an expanded food menu and growth in mobile ordering, the analyst added.
On November 5, the company posted earnings for the third quarter of 2025, reporting earnings per share of $0.19, beating estimates by $0.02. The revenue over time was $423.58 million, up 25.2% year-on-year and beating expectations by $9.98 million. It also updated guidance numbers for the 2025 fiscal year. Total revenues are now projected to be between approximately $1.61 billion and $1.615 billion, versus consensus estimates of $1.60 billion. Same shop sales growth is now expected to be approximately 5%.
Dutch Bros Inc. (NYSE:BROS) operates and franchises drive-thru shops in the United States.
14. ADMA Biologics, Inc. (NASDAQ:ADMA)
Number of Hedge Fund Holders: 42
Next Year Revenue Growth: 26%
Next Year EPS Growth: 56%
Analyst Upside: 59%
ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the stocks that could mint millionaires in 2026.
ADMA Biologics, Inc. (NASDAQ:ADMA) markets BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency, and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics.
In earnings for the third quarter of 2025, the firm provided updated guidance, noting that for 2025, total revenue was now expected to be $510 million, up from prior guidance of more than $500 million. The 2025 adjusted net income was also modestly adjusted to $158 million due to a higher effective tax rate.
ADMA Biologics, Inc. (NASDAQ:ADMA) is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
13. Wingstop Inc. (NASDAQ:WING)
Number of Hedge Fund Holders: 39
Next Year Revenue Growth: 19%
Next Year EPS Growth: 28%
Analyst Upside: 62%
Wingstop Inc. (NASDAQ:WING) is one of the stocks that could mint millionaires in 2026.
On December 9, RBC Capital analyst Logan Reich raised the price target on Wingstop Inc. (NASDAQ:WING) stock to $350 from $300 and kept an Outperform rating on the shares. In an investor note, the analyst noted that the company’s best-in-class franchisee ROIC should support double-digit unit growth while adding that Wingstop had a long runway in the US and was still in the early stages of international expansion.
Wingstop Inc. (NASDAQ:WING) posted earnings for the third quarter of 2025 in early November, reporting earnings per share of $1.02, beating estimates by $0.11. The revenue over time was $175.7 million, up 8.1% year-on-year but missing expectations by $9.62 million. The firm also provided updated guidance numbers for 2025, saying it expected approximately 3% to 4% decline for domestic same-store sales growth, 475 to 485 global net new units, and SG&A of between $131 and $132 million.
Wingstop Inc. (NASDAQ:WING) franchises and operates restaurants under the Wingstop brand.
